Li Liang
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Immunology
- Cancer Research top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Pharmacological Effects of Natural Compounds (4 papers)RNA modifications and cancer (4 papers)
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsJournal of Clinical Oncology
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Liang
60 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 554
- Oncology 389
- Pulmonary and Respiratory Medicine 191
- Immunology 187
- Cancer Research 178
Countries citing papers authored by Li Liang
This map shows the geographic impact of Li Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Liang more than expected).
Fields of papers citing papers by Li Liang
This network shows the impact of papers produced by Li Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Liang. The network helps show where Li Liang may publish in the future.
Co-authorship network of co-authors of Li Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Li Liang. A scholar is included among the top collaborators of Li Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Liang. Li Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 12 | |
| 9 | 8 | |
| 10 | 23 | |
| 11 | 15 | |
| 12 | 3 | |
| 13 | 1 | |
| 14 | 8 | |
| 15 | 21 | |
| 16 | 34 | |
| 17 | 35 | |
| 18 | 27 | |
| 19 | 26 | |
| 20 | RELATIONSHIP BETWEEN INTERNAL ORGAN(VISCERA) AND ACUPOINTS:TOWARD MERIDIAN THEORY | 2 |
About Li Liang
Li Liang is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Pharmacological Effects of Natural Compounds (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Oncology (389 citations), Transplantation (33 citations) and Cancer Research (178 citations). Li Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Youqiong Ye, Gordon B. Mills, Lixia Diao, Ying Jing, Leng Han, Hong Liu, Wei Kang, Jun Yu, Wai Nok Chan and Ka‐Fai To. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.